Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017 | Zendy

Kathleen M. Powis | Zendy; Yanling Huo | Zendy; Paige L. Williams | Zendy; Deborah Kacanek | Zendy; Jennifer Jao | Zendy; Kunjal Patel | Zendy; George R. Seage | Zendy; Russell B. Van Dyke | Zendy; Ellen G. Chadwick | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017

Author(s) -

Kathleen M. Powis,

Yanling Huo,

Paige L. Williams,

Deborah Kacanek,

Jennifer Jao,

Kunjal Patel,

George R. Seage,

Russell B. Van Dyke,

Ellen G. Chadwick

Publication year - 2019

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2019.17669

Subject(s) - human immunodeficiency virus (hiv) , medicine , pregnancy , family medicine , antiretroviral therapy , obstetrics , viral load , genetics , biology

Key Points Question Do antiretroviral prescribing patterns in the United States reflect Department of Health and Human Services prescribing guidelines for pregnant women living with HIV? Findings In this cohort study of antiretroviral prescribing practices during 1867 pregnancies among women living with HIV, only 49.5% of antiretroviral prescriptions were classified as preferred or alternative according to Department of Health and Human Services guidelines. Meaning More than half of the pregnant women living with HIV studied were prescribed antiretroviral regimens categorized by Department of Health and Human Services guidelines as having insufficient evidence for use in pregnancy or for which evidence indicates that use is not recommended.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research